A Study to Evaluate the Long-term Safety and Efficacy of LBEC0101 in Subjects With Active RA Despite Methotrexate (MTX)
NCT02715908 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 148
Last updated 2018-07-06
Summary
To evaluate the long-term safety including immunogenicity and efficacy of LBEC0101 50 mg subcutaneous weekly injection when co-administered with MTX
Conditions
Interventions
- DRUG
-
LBEC0101
Etanercept 50mg
Sponsors & Collaborators
-
LG Life Sciences
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 20 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-04-30
- Primary Completion
- 2017-12-31
- Completion
- 2018-04-30
Countries
- South Korea
Study Locations
More Related Trials
-
Study of LX3305 in Subjects With Active Rheumatoid Arthritis on Stable Methotrexate
NCT00903383 ·Status: COMPLETED ·Phase: PHASE2
-
Study of LX3305 and Methotrexate in Subjects With Stable Rheumatoid Arthritis
NCT00847886 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy, Safety and Tolerability of Secukinumab in Patients With Rheumatoid Arthritis Taking Methotrexate
NCT01359943 ·Status: COMPLETED ·Phase: PHASE2
-
A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adults With Early Active Rheumatoid Arthritis
NCT01521923 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase IIb Study for ALX-0061 Monotherapy in Subjects With Rheumatoid Arthritis
NCT02287922 ·Status: COMPLETED ·Phase: PHASE2
-
A Multi-Site Study to Evaluate the Safety and Effect of Study Drug on Participants With Rheumatoid Arthritis
NCT00308282 ·Status: COMPLETED ·Phase: PHASE2
-
BG9924 in Combination With Methotrexate for Participants With Active Rheumatoid Arthritis
NCT00458861 ·Status: TERMINATED ·Phase: PHASE2
-
Leflunomide + Methotrexate in Rheumatoid Arthritis
NCT00563849 ·Status: COMPLETED ·Phase: PHASE4
-
An Efficacy and Safety Study of Subcutaneous Tocilizumab in Combination With Methotrexate (MTX) and as Monotherapy Versus MTX in Participants With Moderate to Severe Rheumatoid Arthritis With Inadequate Response to Current Disease-Modifying Antirheumatic Drug (DMARD) Therapy
NCT03155347 ·Status: COMPLETED ·Phase: PHASE3
-
A Study for Patients With Rheumatoid Arthritis on Methotrexate (MTX) With an Inadequate Response to TNFα Inhibitor Therapy
NCT00689728 ·Status: COMPLETED ·Phase: PHASE2
-
A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adults With Early Active Rheumatoid Arthritis
NCT01519791 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Study of BG00012 With Methotrexate in Patients With Active Rheumatoid Arthritis
NCT00810836 ·Status: COMPLETED ·Phase: PHASE2
-
A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate
NCT01198002 ·Status: TERMINATED ·Phase: PHASE3
-
A Study of LY2439821 in Rheumatoid Arthritis
NCT01236118 ·Status: COMPLETED ·Phase: PHASE1
-
Subcuteous Methotrexate in Rheumatoid Arthritis
NCT07094880 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Subcutaneous RoActemra/Actemra (Tocilizumab) as Monotherapy or in Combination With Methotrexate or Other Non-Biologic DMARDs in Patients With Active Rheumatoid Arthritis
NCT01995201 ·Status: COMPLETED ·Phase: PHASE3
-
Dose-Escalating Study of BG9924 in Combination With Methotrexate in Active Rheumatoid Arthritis
NCT00292422 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Safety and Efficacy of MabThera (Rituximab) in Combination With Methotrexate (MTX) in Participants With Active Rheumatoid Arthritis Who Failed on Anti-Tumor Necrosis Factor Alpha Therapy
NCT00468546 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Investigate the Efficacy, Safety, and Tolerability of FBL-MTX in Patients With Rheumatoid Arthritis
NCT06565273 ·Status: RECRUITING ·Phase: PHASE2
-
A Study of LY3090106 in Healthy Participants and Participants With Rheumatoid Arthritis (RA)
NCT01925157 ·Status: COMPLETED ·Phase: PHASE1
-
An Open-Label Study of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Active Rheumatoid Arthritis
NCT01951170 ·Status: COMPLETED ·Phase: PHASE3
-
A Long-Term Extension Study of WA22762 to Evaluate Safety and Efficacy of Subcutaneous Tocilizumab in Participants With Moderate to Severe Rheumatoid Arthritis (RA).
NCT01734993 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Subcutaneous (SC) Tocilizumab (RoActemra/Actemra) in Participants With Active Rheumatoid Arthritis (RA) and Inadequate Response to Disease-Modifying Anti-Rheumatic Drugs (DMARDs)
NCT02046616 ·Status: COMPLETED ·Phase: PHASE3
-
Therapeutic Strategy in Patients Treated With Methotrexate for Rheumatoid Arthritis
NCT02288520 ·Status: COMPLETED
-
A Study to Evaluate the Safety and Efficacy of Rituximab in Combination With Methotrexate Compared to Methotrexate Alone in Patients With Active Rheumatoid Arthritis
NCT00299130 ·Status: COMPLETED ·Phase: PHASE3